Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ENSION Inc
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Y4P6UDJLXLN3
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Description (provided by applicant): Ension, Inc. has previously developed
integrated blood pump-oxygenator technologies offering many advantages over
current clinical systems. In particular, the small size of the integrated
devices has been well received by our colleagues in the "MedEvac" field as a
potential enabling technology to improve safety of transports with patients on
extracorporeal membrane oxygenation (ECMO) or cardiopulmonary bypass (CPB).
Currently, only 1 percent of the MedEvac emergency transport systems in the
United States are capable of transporting ECMO or CPB patients due to the
physical size, weight, and in-field robustness of the current "portable"
electrical systems. Furthermore, our MedEvac colleagues report that the
complexity of patient transport is exacerbated by the unreliable discharge
characteristics of rechargeable batteries used to power units during portable
operation.
Preliminary work performed at Ension supports the development of a
new, portable, integrated blood pump-oxygenator that is powered solely by a
standard source of compressed gas. Compressed gas is used to drive the unit
(pump blood) with the exhaust gas redirected into the unit to provide
subsequent oxygenation and decarbonation. If ultimately successful, this
approach will completely eliminate the need for battery power resulting in a
significantly smaller, simpler, and more robust system suitable for emergency
transport uses.
PROPOSED COMMERCIAL APPLICATION: Less than 1% of the MedEvac emergency transport systems in the United States are capable of transporting patients on ECMO, CPB, or a combination of supportive devices. This is problematic since, as healthcare delivery in the United States continues to move to a hub-and-spoke model, MedEvac transport of such critically ill patients is becoming increasingly necessary. The proposed stechnology will enable these MedEvac systems to begin safe transport of this patient population by addressing the limitations posed by size, weight, and in-field robustness of current ECMO/CPB systems used for this purpose.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Research funding history
27 SBIR/STTR records share this UEI (2001–2025). Reported award amounts total $14,034,077. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Defense
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards